Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Pfizer Inc. recently announced that the U.S. Food and Drug Administration (FDA) ···【more】
Release date：2026-01-23Recommended：227
Pfizer recently announced that the U.S. Food and Drug Administration (FDA) has a···【more】
Release date：2026-01-23Recommended：256
On January 28, 2022, Pfizer Inc. announced that the European Commission (EC) had···【more】
Release date：2026-01-23Recommended：216
At present, the core objective of research related to ponatinib is to improve it···【more】
Release date：2026-01-21Recommended：235
Patients should maintain a written list of all prescription drugs, over-the-coun···【more】
Release date：2026-01-21Recommended：220
This medicine may cause fluid retention and heart failure. If you experience rap···【more】
Release date：2026-01-21Recommended：256
Ponatinib exerts its therapeutic effect by inhibiting cancer cell proliferation ···【more】
Release date：2026-01-21Recommended：282
Ponatinib is a targeted therapy indicated for the treatment of specific types of···【more】
Release date：2026-01-21Recommended：292
Ponatinib is a targeted therapy for the treatment of specific types of leukemia.···【more】
Release date：2026-01-21Recommended：220
Ponatinib is indicated for the treatment of specific types of chronic myeloid le···【more】
Release date：2026-01-21Recommended：211
Ponatinib is an oral tyrosine kinase inhibitor primarily indicated for the treat···【more】
Release date：2026-01-20Recommended：237
Ponatinib is a third-generation tyrosine kinase inhibitor (TKI) primarily indica···【more】
Release date：2026-01-20Recommended：280
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
